featured
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine ± Concomitant Azithromycin in COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
JAMA Cardiol 2020 May 01;[EPub Ahead of Print], NJ Mercuro, CF Yen, DJ Shim, TR Maher, CM McCoy, PJ Zimetbaum, HS GoldFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.